Aripiprazole 2-month ready-to-use 960 mg (Ari 2MRTU): review of its possible role in schizophrenia therapy
BT Baune - Current Medical Research and Opinion, 2024 - Taylor & Francis
Most patients with schizophrenia need life-long treatment. There is therefore a continued
need for effective and tolerable treatment options. A 2-monthly LAI formulation of …
need for effective and tolerable treatment options. A 2-monthly LAI formulation of …
[HTML][HTML] Gut microbial dysbiosis and cognitive impairment in bipolar disorder: Current evidence
W Dai, Y Qiu, Z Teng, S Li, J Huang, H Tang… - Frontiers in …, 2022 - frontiersin.org
Recent studies have reported that the gut microbiota influences mood and cognitive function
through the gut-brain axis, which is involved in the pathophysiology of neurocognitive and …
through the gut-brain axis, which is involved in the pathophysiology of neurocognitive and …
Aripiprazole combined with nerve growth factor improves cognitive function in mice with schizophrenia model
C Lu, S Li, L Kang, Q Li, H Chen, Y Lin, H Zhang… - Neuroscience …, 2023 - Elsevier
The pathogenesis and treatment of cognitive dysfunction in patients with schizophrenia
(SCZ) remains a challenge. Exploring new effective treatment strategies is relevant for the …
(SCZ) remains a challenge. Exploring new effective treatment strategies is relevant for the …
Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D2/5-HT receptor …
I Vojtechova, K Tuckova, R Juza, A Stuchlik… - Progress in Neuro …, 2023 - Elsevier
Dopamine type 2 receptors (D 2 Rs) constitute the main molecular target in the
pharmacotherapy of schizophrenia. However, the second and third generation of …
pharmacotherapy of schizophrenia. However, the second and third generation of …
帕利哌酮缓释片联合阿立哌唑对精神分裂症精神病性症状, 认知功能和催乳素的影响
黄锦， 朱丞 - 中华全科医学, 2022 - zhqkyx.net
目的探讨帕利哌酮缓释片, 阿立哌唑联合治疗对精神分裂症精神病性症状和认知功能的改善作用
及对催乳素的影响. 方法2019 年9 月—2021 年9 月建德市第四人民医院招募精神分裂症患者96 …
及对催乳素的影响. 方法2019 年9 月—2021 年9 月建德市第四人民医院招募精神分裂症患者96 …
[HTML][HTML] Effect of catechol-O-methyltransferase genotype polymorphism on neurological and psychiatric disorders: progressing towards personalized medicine
K Srivastava, O Ochuba, JK Sandhu, T Alkayyali… - Cureus, 2021 - ncbi.nlm.nih.gov
Different polymorphisms of the catechol-O-methyltransferase (COMT) gene affect the COMT
enzyme activity. The COMT enzyme plays a major role in the pathophysiology of various …
enzyme activity. The COMT enzyme plays a major role in the pathophysiology of various …
Treatment goals in schizophrenia: a real-world survey of patients, psychiatrists, and caregivers in the United States, with an analysis of current treatment (long-acting …
HM Fitzgerald, J Shepherd, H Bailey… - Neuropsychiatric …, 2021 - Taylor & Francis
Purpose To understand similarities and differences in patient treatment goals as selected by
US psychiatrists, adult patients with schizophrenia, and their caregivers in a real-world …
US psychiatrists, adult patients with schizophrenia, and their caregivers in a real-world …
Genetic profile for dopamine signaling predicts brain functional reactivity to repetitive transcranial magnetic stimulation
H Hong, RY Kim, Y Song, C Suh, H Lee, IK Lyoo… - European Archives of …, 2023 - Springer
Research integrating molecular and imaging data provides important insights into how the
genetic profile associated with dopamine signaling influences inter-individual differences in …
genetic profile associated with dopamine signaling influences inter-individual differences in …
[HTML][HTML] Association between MTHFR (677C>T and 1298A>C) polymorphisms and psychiatric disorder: A meta-analysis
X Meng, J Zheng, M Sun, H Lai, B Wang, J Yao… - Plos one, 2022 - journals.plos.org
Recent studies showed that genetic polymorphism of 5, 10-methylenetetrahydrofolate
reductase (MTHFR) is related to attention-deficit hyperactivity disorder (ADHD), bipolar …
reductase (MTHFR) is related to attention-deficit hyperactivity disorder (ADHD), bipolar …
[HTML][HTML] Clinical Experience on the Use of a Single-day, Two-injection Start Initiation Regimen of Aripiprazole Once Monthly in Patients With Schizophrenia in Spain …
M Bioque, MJ Moreno, S Gómez-Lus… - Journal of Psychiatric …, 2024 - journals.lww.com
Objective: The two-injection start (TIS) initiation regimen was recently approved for
aripiprazole once monthly 400 mg (AOM400), with potential benefits in adherence. The …
aripiprazole once monthly 400 mg (AOM400), with potential benefits in adherence. The …